These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
183 related items for PubMed ID: 21861843
1. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA). Leira R, Sobrino T, Blanco M, Campos F, Rodríguez-Yáñez M, Castellanos M, Moldes O, Millán M, Dávalos A, Castillo J. Clin Sci (Lond); 2012 Feb; 122(3):113-9. PubMed ID: 21861843 [Abstract] [Full Text] [Related]
2. The effect of physiologic derangement in patients with stroke treated with thrombolysis. Idicula TT, Waje-Andreassen U, Brogger J, Naess H, Lundstadsveen MT, Thomassen L. J Stroke Cerebrovasc Dis; 2008 Feb; 17(3):141-6. PubMed ID: 18436155 [Abstract] [Full Text] [Related]
3. Hyperglycemia during ischemia rapidly accelerates brain damage in stroke patients treated with tPA. Ribo M, Molina CA, Delgado P, Rubiera M, Delgado-Mederos R, Rovira A, Munuera J, Alvarez-Sabin J. J Cereb Blood Flow Metab; 2007 Sep; 27(9):1616-22. PubMed ID: 17299452 [Abstract] [Full Text] [Related]
4. Relative recirculation: a fast, model-free surrogate for the measurement of blood-brain barrier permeability and the prediction of hemorrhagic transformation in acute ischemic stroke. Wu S, Thornhill RE, Chen S, Rammo W, Mikulis DJ, Kassner A. Invest Radiol; 2009 Oct; 44(10):662-8. PubMed ID: 19724234 [Abstract] [Full Text] [Related]
5. Influence of pretreatment MRI parameters on clinical outcome, recanalization and infarct size in 49 stroke patients treated by intravenous tissue plasminogen activator. Derex L, Nighoghossian N, Hermier M, Adeleine P, Berthezène Y, Philippeau F, Honnorat J, Froment JC, Trouillas P. J Neurol Sci; 2004 Oct 15; 225(1-2):3-9. PubMed ID: 15465079 [Abstract] [Full Text] [Related]
6. Predictors and early outcome of hemorrhagic transformation after acute ischemic stroke. Kablau M, Kreisel SH, Sauer T, Binder J, Szabo K, Hennerici MG, Kern R. Cerebrovasc Dis; 2011 Oct 15; 32(4):334-41. PubMed ID: 21921596 [Abstract] [Full Text] [Related]
7. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study. Kwiatkowski T, Libman R, Tilley BC, Lewandowski C, Grotta JC, Lyden P, Levine SR, Brott T, National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. Ann Emerg Med; 2005 Apr 15; 45(4):377-84. PubMed ID: 15795715 [Abstract] [Full Text] [Related]
8. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke. Jucevičiūtė N, Mikužis P, Balnytė R. BMC Neurol; 2019 Jun 13; 19(1):127. PubMed ID: 31195995 [Abstract] [Full Text] [Related]
9. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients. Kimura K, Iguchi Y, Shibazaki K, Kobayashi K, Uemura J, Aoki J, Yamashita S, Terasawa Y, Matsumoto N. J Neurol Sci; 2008 Jul 15; 270(1-2):48-52. PubMed ID: 18304581 [Abstract] [Full Text] [Related]
10. Early blood-brain barrier disruption in human focal brain ischemia. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Ann Neurol; 2004 Oct 15; 56(4):468-77. PubMed ID: 15389899 [Abstract] [Full Text] [Related]
11. Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke. Ning M, Furie KL, Koroshetz WJ, Lee H, Barron M, Lederer M, Wang X, Zhu M, Sorensen AG, Lo EH, Kelly PJ. Neurology; 2006 May 23; 66(10):1550-5. PubMed ID: 16717217 [Abstract] [Full Text] [Related]
12. Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator. Rodríguez-González R, Blanco M, Rodríguez-Yáñez M, Moldes O, Castillo J, Sobrino T. Atherosclerosis; 2013 Jan 23; 226(1):165-71. PubMed ID: 23218119 [Abstract] [Full Text] [Related]
13. Acute stroke management in the elderly. Zeevi N, Chhabra J, Silverman IE, Lee NS, McCullough LD. Cerebrovasc Dis; 2007 Jan 23; 23(4):304-8. PubMed ID: 17199089 [Abstract] [Full Text] [Related]
14. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, Harnett K, Schwiderski U, Gammans R. Ann Neurol; 2000 Nov 23; 48(5):713-22. PubMed ID: 11079534 [Abstract] [Full Text] [Related]
15. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke. Nakashima T, Toyoda K, Koga M, Matsuoka H, Nagatsuka K, Takada T, Naritomi H, Minematsu K. Int J Stroke; 2009 Dec 23; 4(6):425-31. PubMed ID: 19930051 [Abstract] [Full Text] [Related]
16. Hyperthermia is a surrogate marker of inflammation-mediated cause of brain damage in acute ischaemic stroke. Leira R, Rodríguez-Yáñez M, Castellanos M, Blanco M, Nombela F, Sobrino T, Lizasoain I, Dávalos A, Castillo J. J Intern Med; 2006 Oct 23; 260(4):343-9. PubMed ID: 16961671 [Abstract] [Full Text] [Related]
18. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke. Miedema I, Uyttenboogaart M, Koopman K, De Keyser J, Luijckx GJ. Cerebrovasc Dis; 2010 Feb 23; 29(3):263-7. PubMed ID: 20090317 [Abstract] [Full Text] [Related]